DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed’s (NASDAQ: ABMD) Impella ECP expandable percutaneous heart ...
Impella ECP is the world’s smallest heart pump. It achieves peak flows greater than 3.5 L/min and is delivered through a slender-profile sheath. It is un-sheathed in the descending aorta and expands ...
Hosted on MSN
How ECP therapy boosts circulation and heart health
Good health depends on strong circulation. Blood flow carries oxygen and nutrients to every part of the body-including the heart, brain, skin, and muscles. When circulation is impaired, the body ...
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart ...
Heart patients have all types of procedures and medications to help them live longer but many say their quality of life could be better. Now, those patients have an option. and other hospitals are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback